Results 251 to 260 of about 13,800,549 (299)

Lipoproteins and diuretics in type II diabetes

Journal of Diabetic Complications, 1991
This double-blind cross-over study was performed to investigate whether the lipoproteins in plasma were different on furosemide (Lasix Retard) and thiazide (hydrochlorthiazide) treatment in patients suffering from type II diabetes. Twenty-four patients were randomly allocated to either furosemide-hydrochlorthiazide (LR-HCT) or HCT-LR treatment.
A, Møller, A, Schmitz, M M, Pedersen, J S, Christiansen   +3 more
openaire   +2 more sources

Economic Evaluations of Type II Diabetes

PharmacoEconomics, 1995
Economic analyses, which can be either descriptive or evaluative, can help to ensure that healthcare resources are used effectively. Most studies of diabetes mellitus have been descriptive and have used the cost-of-illness methodology, which estimates the burden of a disease to society.
openaire   +2 more sources

Marital relationships and Type II diabetes.

Family Systems Medicine, 1994
This study investigates how couples in whixh a spouse suffers from noninsulin dependent diabetes will cope with chronic diabetes illness. A Multimethod project was devised, based on Rolland's model, and applied in the context of theories abput the family life cycle.
Cigoli, Vittorio, Binda, Vilma Rita, Marta, Elena   +2 more
openaire   +1 more source

Bromocriptine for Diabetes Mellitus Type II

Cardiology in Review, 2011
A quick-release formulation of bromocriptine is the latest drug approved by the US Food and Drug Administration for the treatment of type 2 diabetes mellitus. Most interestingly, the development of this drug stems from studies of hibernation in rodents. This article will review the physiology that led to the development of this new drug, as well as its
openaire   +2 more sources

Insulin Therapy in Type II Diabetes

Diabetes Care, 1993
Administration of exogenous insulin can ameliorate metabolic abnormalities in type II diabetes: It compensates for reduced endogenous insulin secretion, reduces excessive hepatic glucose production, and stimulates glucose uptake, enhancing both glucose oxidation and storage in the muscle tissue. In addition, insulin therapy has anti-atherogenic effects
openaire   +2 more sources

Eating Right With Type II Diabetes

The Physician and Sportsmedicine, 1992
(1992). Eating Right With Type II Diabetes. The Physician and Sportsmedicine: Vol. 20, No. 9, pp. 17-18.
openaire   +2 more sources

Insulin Secretion in Type II Diabetes

1998
info:eu-repo/semantics ...
openaire   +2 more sources

Intensive management of type II diabetes

Postgraduate Medicine, 1991
The goals of intensive treatment of type II diabetes are to restore blood glucose levels to normal; correct hyperlipidemia, hypertension, and other cardiovascular risk factors; and prevent hyperinsulinemia. Treatment should begin with attempts to reduce weight through diet and exercise.
openaire   +3 more sources

Lipid metabolism in type II diabetes

Postgraduate Medicine, 1992
Hypertension, dyslipidemia, insulin resistance, and hyperinsulinemia--acknowledged risk factors for coronary artery disease--are all more common in persons with non-insulin-dependent diabetes than in nondiabetic persons. The interrelationships of these risk factors are becoming increasingly recognized.
openaire   +2 more sources

Preventing Type II Diabetes Mellitus

The Journal of Clinical Pharmacology, 2004
Burgeoning obesity is increasing the prevalence of type II diabetes mellitus. As a consequence, there will be an even greater burden of cardiovascular disease, end‐stage renal disease, blindness, and lower extremity amputations. If diagnosed, impaired glucose tolerance presents an opportunity for intervention that potentially could delay or prevent the
openaire   +2 more sources